Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease
Kim, Dong-Hyun, Lee, Kyeong-Jin, Park, JinJoo, Chi, Susan, Han, Jaekyu, Bang, Yewon, Kim, Sun-Mi, Kang, Seung Goo, Cha, Sang-Hoon, Han, Yong-Hyun
Published in Biomedicine & pharmacotherapy (01.11.2023)
Published in Biomedicine & pharmacotherapy (01.11.2023)
Get full text
Journal Article